Superoxide dismutase as a target for the selective killing of cancer cells
- PMID: 11014196
- DOI: 10.1038/35030140
Superoxide dismutase as a target for the selective killing of cancer cells
Abstract
Superoxide dismutases (SOD) are essential enzymes that eliminate superoxide radical (O2-) and thus protect cells from damage induced by free radicals. The active O2- production and low SOD activity in cancer cells may render the malignant cells highly dependent on SOD for survival and sensitive to inhibition of SOD. Here we report that certain oestrogen derivatives selectively kill human leukaemia cells but not normal lymphocytes. Using complementary DNA microarray and biochemical approaches, we identify SOD as a target of this drug action and show that chemical modifications at the 2-carbon (2-OH, 2-OCH3) of the derivatives are essential for SOD inhibition and for apoptosis induction. Inhibition of SOD causes accumulation of cellular O2- and leads to free-radical-mediated damage to mitochondrial membranes, the release of cytochrome c from mitochondria and apoptosis of the cancer cells. Our results indicate that targeting SOD may be a promising approach to the selective killing of cancer cells, and that mechanism-based combinations of SOD inhibitors with free-radical-producing agents may have clinical applications.
Comment in
-
Cancer. A radical approach to treatment.Nature. 2000 Sep 21;407(6802):309-11. doi: 10.1038/35030277. Nature. 2000. PMID: 11014172 No abstract available.
Similar articles
-
Inhibition of superoxide dismutase by 2-methoxyoestradiol analogues and oestrogen derivatives: structure-activity relationships.Anticancer Drug Des. 2001 Aug-Oct;16(4-5):209-15. Anticancer Drug Des. 2001. PMID: 12049479
-
A radical approach to cancer.Med Sci Monit. 2002 Apr;8(4):RA79-92. Med Sci Monit. 2002. PMID: 11951081 Review.
-
2-methoxyestradiol does not inhibit superoxide dismutase.Arch Biochem Biophys. 2001 Aug 15;392(2):349-53. doi: 10.1006/abbi.2001.2455. Arch Biochem Biophys. 2001. PMID: 11488612
-
A super way to kill cancer cells?Nat Med. 2000 Oct;6(10):1105-6. doi: 10.1038/80436. Nat Med. 2000. PMID: 11017139 No abstract available.
-
Mitochondrial superoxide dismutase: a promising target for new anticancer therapies.Curr Med Chem. 2004 May;11(10):1299-308. doi: 10.2174/0929867043365297. Curr Med Chem. 2004. PMID: 15134521 Review.
Cited by
-
Exploring the 3,5-Dibromo-4,6-dimethoxychalcones and Their Flavone Derivatives as Dual α-Glucosidase and α-Amylase Inhibitors with Antioxidant and Anticancer Potential.Antioxidants (Basel). 2024 Oct 17;13(10):1255. doi: 10.3390/antiox13101255. Antioxidants (Basel). 2024. PMID: 39456508 Free PMC article.
-
Neuroprotective effect of Bouvardia ternifolia (Cav.) Schltdl via inhibition of TLR4/NF-κB, caspase-3/Bax/Bcl-2 pathways in ischemia/reperfusion injury in rats.Front Pharmacol. 2024 Sep 23;15:1471542. doi: 10.3389/fphar.2024.1471542. eCollection 2024. Front Pharmacol. 2024. PMID: 39376599 Free PMC article.
-
Insights into Molecular Mechanisms of Anticancer Activity of Juniperus communis Essential Oil in HeLa and HCT 116 Cells.Plants (Basel). 2024 Aug 23;13(17):2351. doi: 10.3390/plants13172351. Plants (Basel). 2024. PMID: 39273835 Free PMC article.
-
Oxidative cell death in cancer: mechanisms and therapeutic opportunities.Cell Death Dis. 2024 Aug 1;15(8):556. doi: 10.1038/s41419-024-06939-5. Cell Death Dis. 2024. PMID: 39090114 Free PMC article. Review.
-
Fluorescence imaging sheds light on the immune evasion mechanisms of hepatic stellate cells mediated by superoxide anion.Commun Biol. 2024 May 10;7(1):558. doi: 10.1038/s42003-024-06245-y. Commun Biol. 2024. PMID: 38730013 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
